Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Objective. To prospectively evaluate the effect of intravitreal bevacizumab on aqueous levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in patients with exudative age-related macular degeneration (AMD) and correlate clinical outcomes with cytokine levels. Methods. 30 eyes...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chalam, Kakarla V., Grover, Sandeep, Sambhav, Kumar, Balaiya, Sankarathi, Murthy, Ravi K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2014
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121253/
https://ncbi.nlm.nih.gov/pubmed/25110587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/502174
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi